FDA.reportPublic FDA data

dapsone 0.05 MG/MG Topical Gel [Aczone]

RxCUI
701858
RxNorm name
dapsone 0.05 MG/MG Topical Gel [Aczone]
Display name
dapsone 0.05 MG/MG Topical Gel [Aczone]
Full name
dapsone 0.05 MG/MG Topical Gel [Aczone]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b7d605cf-bf84-461b-939b-1f773a4cba65Aczone 5 % Topical Gel [PSN] · dapsone 0.05 MG/MG Topical Gel [Aczone] [SBD] · Aczone 0.05 MG/MG Topical Gel [SY] · Aczone 5 % Topical Gel [SY]416These highlights do not include all the information needed to use ACZONE ® Gel, 5% safely and effectively. See full prescribing information for ACZONE ® Gel, 5%. ACZONE ® (dapsone) Gel, 5%, for topical use Initial U.S. Approval: 195520180528